Easton Pharmaceuticals, Inc. (EAPH)

[wjb007]

ADDITIONAL EAPH REVENUES: “Grin and BAYER it”; In addition to the EAPH/AG AGGREGATE REVENUES; EAPH along with BMV; EAPH/BMV invested MILLIONS into the licensing and distribution rights in Mexico/South American countries and then closed on joint ventures with several Big Pharma Companies; BAYER and others, for ROYALTIES REVENUES that are anticipated to start later this year or early 2019 and the EAPH REVENUES will continue for years and coincide with the forthcoming EAPH 5 year plan.

Major Developments With Pending Announcements Are Expected To Soon Be Disclosed...Announcement Will Also Confirm That Easton Will NOT Be Undertaking Any Reverse Splits Of It’s Common Stock. BAYER Update Announcements Pending Along With Other Significant Positive Developments.